Device Trial Radar · NCT06144632
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF
Last checked: Nov 20, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
237
Actual
Start
Dec 7, 2023
Primary completion
Oct 30, 2025
Study completion Oct 30, 2025
Sponsor
- Lead sponsor
- Biosense Webster, Inc.Public (JNJ)
- Sponsor type
- Industry
- First posted
- Nov 22, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate safety and effectiveness of the Biosense Webster (BWI) ablation system (THERMOCOOL SMARTTOUCH surround flow \[STSF\] catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of participants with paroxysmal atrial fibrillation (PAF), an irregular heart rate that causing abnormal blood flow.
Conditions
- Drug Refractory Paroxysmal Atrial Fibrillation
Interventions
THERMOCOOL STSF Bi- Directional Navigation CatheterDevice
THERMOCOOL STSF will be used in conjunction with TRUPULSE Generator to give pulsed field (PF) ablation or radiofrequency (RF) ablation.
TRUPULSE GeneratorDevice
TRUPULSE Generator will be used to deliver PF/RF ablation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Primary Adverse Events (PAEs)Time frame: 7 days post-procedure
- Percentage of Participants with Freedom from Documented (Symptomatic and Asymptomatic) Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes and Other Failure ModesTime frame: Up to 274 days
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Grandview Medical Center
Birmingham, Alabama
University of Alabama at Birmingham
Birmingham, Alabama
Keck School of Medicine of USC
Los Angeles, California
26 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.